Get started
Author

Charisma Mylavarapu

ORCID: 0000-0003-1789-0022
Observed ORCID: 0000-0003-1789-0022
OpenAlex ID: A5042078196
Pancreatic head vs pancreatic body/tail cancer: Are they different?
2022 · Kai Sun, Charisma Mylavarapu, et al. · World Journal of Gastrointestinal Oncology · 20
Impact of Infections in Patients Receiving Pembrolizumab-Based Therapies for Non-Small Cell Lung Cancer
2022 · Ethan A. Burns, Kelly Gee, et al. · Cancers · 14
PDF
Consuming Genistein Improves Survival Rates in the Absence of Laxative in ΔF508-CF Female Mice
2018 · Ryan Lord, Nathan Fairbourn, et al. · Nutrients · 12
PDF
Clinical factors and association with treatment modalities in patients with breast cancer and brain metastases who develop leptomeningeal metastases
2022 · Akshjot Puri, Charisma Mylavarapu, et al. · Breast Cancer Research and Treatment · 7
PDF
Case report: Efficacy and safety of regorafenib plus fluorouracil combination therapy in the treatment of refractory metastatic colorectal cancer
2022 · Emaan Haque, Ibrahim N. Muhsen, et al. · Frontiers in Oncology · 5
PDF
Diffuse Cerebral Edema and Impending Herniation Complicating Hepatic Encephalopathy in Hereditary Hemorrhagic Telangiectasia
2022 · Charisma Mylavarapu, Alexander J. Lu, et al. · Case Reports in Medicine · 3
PDF
Bloodless Management of Severe Refractory ITP and Acute Hemorrhage in a Jehovah's Witness Patient
2025 · Gagandeep Kaur, Shanley Banaag, et al. · Clinical Case Reports · 1
PDF
Outcomes of patients with advanced urothelial cancer who develop infection while on treatment with pembrolizumab.
2022 · Ryan Blair Kieser, Jiaqiong Xu, et al. · Journal of Clinical Oncology · 1
Infections and their impact on patients on pembrolizumab-based therapies for head and neck cancer.
2022 · Yuqi Zhang, Jiaqiong Xu, et al. · Journal of Clinical Oncology · 1
Real-world experience of pancreatic cancer molecular profiling in a tertiary center.
2021 · Kai Sun, Charisma Mylavarapu, et al. · Journal of Clinical Oncology · 1
Hematologic/Oncologic Causes of Headache
2024 · Diana V. Maslov, Shanley Banaag, et al. · CRC Press eBooks
480 Impact of infections in patients with advanced or metastatic non-small cell lung cancer (NSCLC) receiving pembrolizumab-based therapies
2022 · Ethan Burns, Jiaqiong Xu, et al. · Journal for ImmunoTherapy of Cancer
PDF
Outcomes in non-small cell lung cancer (NSCLC) patients treated with second-line therapy after progression or recurrence after initial first line immune checkpoint-based therapy.
2022 · Ibrahim Muhsen, Charisma Mylavarapu, et al. · Journal of Clinical Oncology
Systemic chemotherapy in patients with brain only metastatic breast cancer: A retrospective analysis.
2021 · Akshjot Puri, Charisma Mylavarapu, et al. · Journal of Clinical Oncology
Abstract PS14-08: Clinical factors and association with treatment modalities in patients with breast cancer and brain metastases who develop leptomeningeal disease
2021 · Akshjot Puri, Charisma Mylavarapu, et al. · Cancer Research
In the absence of weight gain, survival rates of DF508‐CF female mice are increased by genistein diet.
2018 · Layla Al‐Nakkash, Nathan Fairbourn, et al. · The FASEB Journal
Works count: 16
Citation count: 65
H-index: 5
I10-index: 3
Year
Topic
Type